IPSCs have been used as disease models for Fragile X syndrome [143–145] and Rett syndrome [146], and iPSCs have been generated from patents with deletions in SHANK3 [147] which are implicated in a number of neurodevelopmental disorders. Here, SHANK3 is linked to fragile X syndrome.